Publications by authors named "Kenneth D Anderson"

Claim this Profile
D
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRAS Inhibitor.
Xiaoshen Ma, David L Sloman, Ruchia Duggal, Kenneth D Anderson, Jeanine E Ballard

J Med Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Biomarker of Neuronal Glutamate Metabolism in Nonhuman Primates Using Localized H-Magnetic Resonance Spectroscopy: Development and Effects of BNC375, an α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator.
Corin O Miller, Liza T Gantert, Stephen F Previs, Ying Chen, Kenneth D Anderson

Biol Psychiatry Cogn Neurosci Neuroimaging· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyethlyene Glycol 200 Can Protect Rats Against Drug-Induced Kidney Toxicity Through Inhibition of the Renal Organic Anion Transporter 3.
Yi-Zhong Gu, Xiaoyan Chu, Robert Houle, Katerina Vlasakova, Kenneth A Koeplinger, Kenneth D Anderson

Toxicol Sci· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microsampling: considerations for its use in pharmaceutical drug discovery and development.
Neil Spooner, Kenneth D Anderson, Joe Siple, Enaksha R Wickremsinhe, Yang Xu

Bioanalysis· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biaryl ethers as potent allosteric inhibitors of reverse transcriptase and its key mutant viruses: aryl substituted pyrazole as a surrogate for the pyrazolopyridine motif.
Dai-Shi Su, John J Lim, Elizabeth Tinney, Thomas J Tucker, Sandeep Saggar, Kenneth D Anderson

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the prototype serotonin 5-HT(1B/1D) receptor agonist sumatriptan and the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP(8-37) on myocardial reactive hyperemic response in conscious dogs.
Joseph J Lynch, You-Tang Shen, Tamara J Pittman, Kenneth D Anderson, Kenneth S Koblan

Eur J Pharmacol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biaryl ethers as novel non-nucleoside reverse transcriptase inhibitors with improved potency against key mutant viruses.
Dai-Shi Su, John J Lim, Elizabeth Tinney, Bang-Lin Wan, Mary Beth Young, Kenneth D Anderson

J Med Chem· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants.
Dai-Shi Su, John J Lim, Elizabeth Tinney, Bang-Lin Wan, Mary Beth Young, Kenneth D Anderson

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripherally administered non-peptide oxytocin antagonist, L368,899, accumulates in limbic brain areas: a new pharmacological tool for the study of social motivation in non-human primates.
Maria L Boccia, Anne-Pierre S Goursaud, Jocelyne Bachevalier, Kenneth D Anderson, Cort A Pedersen

Horm Behav· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo cardiac electrophysiologic and antiarrhythmic effects of an isoquinoline IKur blocker, ISQ-1, in rat, dog, and nonhuman primate.
Christopher P Regan, Gary L Stump, Audrey A Wallace, Kenneth D Anderson, Charles J McIntyre

J Cardiovasc Pharmacol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of novel isoquinoline-3-nitriles as orally bioavailable Kv1.5 antagonists for the treatment of atrial fibrillation.
B Wesley Trotter, Kausik K Nanda, Nathan R Kett, Christopher P Regan, Joseph J Lynch, Kenneth D Anderson

J Med Chem· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor.
Fumi Kinose, Giuseppe Roscilli, Stefania Lamartina, Kenneth D Anderson, Fabio Bonelli

Mol Vis· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NR2B-selective N-methyl-D-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazoles.
John A McCauley, Cory R Theberge, Joseph J Romano, Susan B Billings, Kenneth D Anderson

J Med Chem· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally efficacious NR2B-selective NMDA receptor antagonists.
Christopher F Claiborne, John A McCauley, Brian E Libby, Neil R Curtis, Helen J Diggle, Kenneth D Anderson

Bioorg Med Chem Lett· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis